Asserting that research and innovation propel a country towards development, Union Health Minister Mansukh Mandaviya on Thursday said it was time for India to demonstrate its mettle through entrepreneurship and innovation in the health sector.
He said that under the leadership and guidance of Prime Minister Narendra Modi, India has taken several notable steps towards self-reliance, especially in vaccine development during the pandemic.
Mandaviya and his deputy Bharti Pravin Pawar launched the 'ICMR/DHR Policy on Biomedical Innovation and Entrepreneurship for Medical Professionals, Scientists and Technologists at Medical, Dental, Para-Medical Institutes/ Colleges'.
"I am very hopeful that this policy of DHR-ICMR will motivate, incentivise and give a fillip to all stakeholders.
"It will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at the medical institutes across the country," Mandaviya said.
He said it was time that India also "demonstrates its strength and mettle through research, entrepreneurship and innovative initiatives in the health sector, including medical devices".
"Our medical workforce comprising doctors, paramedical staff, technicians have a wealth of knowledge... They also have ideas for innovations. Till now, these could not get a policy framework and platform for further growth."
This ICMR/DHR policy will connect the industry, technical institutions and promote commercial translation of these ideas and innovations in the health sector, he said.
Pawar appreciated the initiative and congratulated DHR and ICMR for bringing out the policy document and said that doctors and medical professionals are ideally positioned to be at the forefront of innovation and research.
According to the policy, medical professionals will be encouraged to pursue entrepreneurial ventures by forming startups, taking an adjunct position in company non-executive director or scientific advisor, the health ministry said.
The medical professionals will also be permitted to take up sabbatical for translational and commercialisation of their innovation through their start-up company set up following the institute's permission.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)